EKB Journal Management System
1.

Effect of Dapagliflozin in Type II Diabetic Patients Presenting with Acute Myocardial Infarction and Stage B Heart Failure

Articles in Press, Accepted Manuscript , Available Online from 28 August 2025
Ahmed Gamal Darwish; Ahmed AL-HABBAA; Ahmad Mohammad Hassaan
2.

The Possible Protective Effect of Dapagliflozin and Moringa Alone or in Combination on The Liver of Type 2 Diabetic Albino Rats: A Biochemichal, Histological and Immunohistochemical Study

Articles in Press, Accepted Manuscript , Available Online from 19 March 2025
nehal fahmy shaheen; Sania Elwia; Hebatallah E Attallah; Hanan Ibrahim Elkerdasy
3.

Short-term effect of Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, on patients with rheumatic mitral regurgitation and preserved left ventricular systolic function.

Articles in Press, Accepted Manuscript , Available Online from 01 July 2024
Hazem Mohammed Farrag; Ragab Ismail Fahim; Mohamed Abdelkader Abdelwahab
4.

The potential association between diabetes mellitus type 2 and depression. Role of L-carnitine. An experimental study on adult albino rats

Articles in Press, Accepted Manuscript , Available Online from 06 February 2025
Abeer Attia Abdel-hameed; Ahmed Selim Mohamed; Omaima Mohammed Abdullah; Mahitab Essam Ahmed Gahgah; Abeer Ali Eldeeb
5.

Role of Dapagliflozin in Protection of Contrast Induced Nephropathy in Patients Eligible for Angiographic Procedures

Volume 31, Issue 11, November 2025, Pages 5250-5261
Asmaa Abdelkarim kenawy; Rehab Yaseen; Walaa farid; Eslam Mohamed Abd Elghany El Habashy
6.

Effect of Dapagliflozin on N-Terminal Prohormone of Brain Natriuretic Peptide and some Biochemical Parameters in Patients with Heart Failure

Volume 11, Issue 3, September 2025, Pages 953-961
Saleh Netish Khashlok; Alyaa Majid
7.

Metformin and Dapagliflozin Halt Breast Cancer Progression in Rats by Targeting microRNA-34a

Volume 45, Issue 3, July 2025, Pages 390-408
Esraa S. Habiba; Mona Hassan Fathelbab; Marwa M. AbdElaziz; Eman A. Allam; Marwa Mahmoud Mady; Soha Elatrebi
8.

Dapagliflozin Exerts Renoprotective Effect by Activating the Nrf2/HO-1 Pathway in Glycerol-Induced Acute Kidney Injury

Volume 100, Issue 1, July 2025, Pages 4231-4239
9.

DEVELOPMENT OF A DISSOLUTION METHOD FOR DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE AND METFORMIN HYDROCHLORIDE TABLETS

Volume 48, Issue 1, June 2025, Pages 121-133
Lubna Majed Alarab Alafandi; Wassim Abdelwahed; Yaser Bitar
10.

DAPAGLIFLOZIN/ CARVEOL COMBINATION AMELIORATES PENTYLENETETRAZOLE INDUCED EPILEPSY IN RATS: ANTIOXIDANT, ANTI-INFLAMMATORY AND ANTI-APOPTOTIC EFFECTS: TARGETING TLR4/MIR-181B/NFKB

Volume 48, Issue 1, June 2025, Pages 665-680
Monira Seleem; Asmaa F. Eltantawy; Ahmed Almeldin; Hoda A. Ibrahim; Rehab El-Gohary; Asmaa Azzam; Sarah Ibrahim; Alaa Elkordy; Heba Faheem
11.

Effects of Dapagliflozin on Renal Function and Metabolic Outcomes in CKD Patients with Type 2 Diabetes

Volume 93, Issue 06, June 2025, Pages 699-706
RAMY IBRAHIM ELWARAKY, M.Sc.*; AMIRA B. KASSEM, Ph.D.*; AHMED FATHI ELKERAIE, M.D.**; GAMAL ABDELHAY OMRAN, Ph.D.*** and NOHA A. EL-BASSIOUNY, Ph.D.*
12.

Impact of Dapagliflozin on Left Ventricular Longitudinal Global Strain and Diastolic Function in Non-Diabetic Patients with Heart Failure with Preserved Ejection Fraction

Volume 99, Issue 1, April 2025, Pages 2404-2412
13.

The gastroprotective effects of dapagliflozin against NSAID-induced ulcerated rats

Volume 4, Issue 2, April 2025, Pages 2454-2470
Ahmed Mohamed Atwa; yasmin tarek saad; Mohamed Magdy Senna
14.

Effect of Dapagliflozin on Left Atrial Strain Parameters in Diabetic Patients with Paroxysmal Atrial Fibrillation

Volume 28, Issue 1, January 2025, Pages 16-27
Fathy Nada; Mohammed El Merry; Ahmed Abdellah
15.

Dapagliflozin's Impact on Cardio-Renal Outcomes in Critically Ill Type 2 Diabetes Mellitus Patients

Volume 8, Issue 1, January 2025, Pages 842-851
Yahya Abdel Tawab Mohammed Meky
16.

Protective effect of dapagliflozin against non-alcoholic fatty liver in rats AMPK/SIRT1 pathway activation

Volume 30, Issue 9, December 2024, Pages 4391-4404
Shaimaa Ashraf Muhammed Alsafty; Dalia M Abd El Motteleb; Ameen M Sekinah; Yassmen Mahmoud EL-sayed
17.

DEVELOPMENT AND VALIDATION OF GREEN HPTLC METHOD FOR SIMULTANEOUS DETERMINATION OF DAPAGLIFLOZIN AND LINAGLIPTIN IN COMBINED DOSAGE FORM

Volume 47, Issue 2, December 2024, Pages 1037-1048
Dhyey Shah; Dhananjay Meshram; Dhara Patel; Prasanna Pradhan; Grishma Patel
18.

Eco-Friendly HPLC Method for Quantification of Metformin and Dapagliflozin in Tablets Dosage Form and Spiked Human Plasma Utilizing Solid Phase Extraction

Volume 67, Issue 10, October 2024, Pages 309-317
Hassan Mosallam Abdel Ftaah Hassan; Mahmoud A. Mohamed; Rehab Khaled Mamoud; Mohamed El-Kassem Mohamed Hassouna
19.

Sodium glucose transporter 2 inhibitor Dapagliflozin Regulates kisspeptin and GABA receptors mRNA expression in hypothalamic arcuate nucleus in polycystic ovary rat model, Can it be a therapeutic target?

Volume 94, Issue 1, January 2024, Pages 621-629
20.

Potential Cardio-protective Role of Dapagliflozin in Post Myocardial Infarction Patients

Volume 3, Issue 2, December 2023, Pages 147-156
mariam melad rafla; Mahmoud Hamdy Abdelraheem; Mohammad Salem Hareedy; SAUD MOHAMED ELSAUGHIER
21.

ASSESSMENT OF GENITAL AND URINARY TRACT INFECTIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH DAPAGLIFLOZIN

Volume 45, Issue 2, December 2022, Pages 953-965
Hiba Mayhoub; Arige BouBou; Nisrin Kaddar
22.

Dapagliflozin Versus Insulin: Which Is Better in Treatment of Diabetic Nephropathy in Albino Rats, Immunohistochemical Study

Volume 14, Issue 1, June 2022, Pages 95-111
Magda E. Ahmed; Abd Elhakem Z. Gabr; Amany M. Shams; Rania N. Sherif; Reham I. taha
23.

Protective Effect of Sodium-Glucose Co-Transporter 2 Inhibitor (Dapagliflozin) on Diabetic Retinopathy in Streptozotocin Induced Diabetes in Rats

Volume 87, March, March 2019, Pages 465-470
HEBA S. SHOUKRY, M.D.; MAHA M. TAHER, M.Sc.; AHMED AMIN, M.Sc.; AHMED ALLAM, M. S c.; YARA SAMY, M. S c.